American tegumentary leishmaniasis mimicking myiasis and granulomatous vasculitis: A case report

Abstract

Rationale: American tegumentary leishmaniasis comprises cutaneous and mucocutaneous manifestations caused by parasitic infections by various Leishmania species. This report details the clinical interventions for a patient with American tegumentary leishmaniasis in Mendoza, Argentina, a non-endemic region.

Patient concerns: A 43-year-old male was admitted to a tertiary care hospital in Mendoza, Argentina Republic with a history of progressive nasal discharge, septal perforation, facial pain, and pruritus. Despite treatment for presumed nasal myiasis and vasculitis with granulomatosis, symptoms persisted.

Diagnosis: American tegumentary leishmaniasis.

Interventions: Intravenous liposomal amphotericin B.

Outcomes: Follow-up at 30 days showed no recurrence of symptoms with a remarkable clinical improvement of the nasal lesion.

Lessons: This case sheds light on the necessity of accurate identification for timely intervention and the need to recognize the diverse manifestations of American tegumentary leishmaniasis to avoid misdiagnosis.

Keywords

American tegumentary leishmaniasis / Diagnosis methods / Myasis / Vasculitis and granulomatosis / Case report

References

[1] Sikorska K, Gesing M, Olszański R, Roszko-Wysokińska A, Szostakowska B, Damme-Ostapowicz KV. Misdiagnosis and inappropriate treatment of cutaneous leishmaniasis: A case report. Trop Dis Travel Med Vaccines 2022; 8(1): 18.

[2] Thakur S, Joshi J, Kaur S. Leishmaniasis diagnosis: An update on the use of parasitological, immunological and molecular methods. J Parasit Dis 2020; 44(2): 253-272.

[3] Pavlidakey PG, Huynh T, McKay KM, Sami N. Leishmaniasis panamensis masquerading as myiasis and sporotrichosis: A clinical pitfall. Case Rep Pathol 2015; 2015: 949670.

[4] García Bustos MF, González-Prieto G, Ramos F, Mora MC, Hashiguchi Y, Parodi C, et al. Clinical and epidemiological features of leishmaniasis in northwestern-Argentina through a retrospective analysis of recent cases. Acta Trop 2016; 154: 125-132.

[5] Cargnelutti DE, Borremans CG, Tonelli RL, Carrizo LC, Salomón MC. Diagnosis of Leishmania infection in a nonendemic area of South America. J Microbiol Immunol Infect 2016; 49(5): 809-812.

[6] Pavlidakey PG, Huynh T, McKay KM, Sami N. Leishmaniasis panamensis masquerading as myiasis and sporotrichosis: A clinical pitfall. Case Rep Pathol 2015; 2015: 949670.

[7] Salomon OD, Bogado De Pascual M, Molinari ML, Verri V. Study of a cutaneous leishmaniasis outbreak in General Vedia, Province of Chaco, 1996. Rev Inst Med Trop Sao Paulo 2001; 43: 99-104.

[8] Martín-Sánchez J, Navarro-Mari JM, Pasquau-Liaño J, Salomón OD, Morillas-Márquez F. Visceral leishmaniasis caused by Leishmania infantum in a Spanish patient in Argentina: What is the origin of the infection? Case report. BMC Infect Dis 2004; 4: 20.

[9] Yadón ZE, Quigley MA, Davies CR, Rodrigues LC, Segura EL. Assessment of leishmaniasis notification system in Santiago del Estero, Argentina, 1990-1993. Am J Trop Med Hyg 2001; 65(1): 27-30.

[10] Montoya NR, Pulgarín JQ, Carvajal LL. Therapeutic response and safety of different treatments for cutaneous leishmaniasis in patients: A retrospective cross-sectional study. Asian Pac J Trop Med 2023; 16(7): 305-312.

[11] Oryan A, Bemani E, Bahrami S. Anti-leishmanial, immunomodulatory and anti-oxidative activity of quercetin against cutaneous leishmaniasis caused by Leishmania major. Asian Pac J Trop Biomed 2023; 13(1): 26-34.